SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-000921
Filing Date
2021-01-28
Accepted
2021-01-27 20:07:48
Documents
15
Period of Report
2021-01-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K sgmo-20210122.htm   iXBRL 8-K 42671
2 EX-10.1 leeconsultingagreementfinal.htm EX-10.1 23209
  Complete submission text file 0001628280-21-000921.txt   217093

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgmo-20210122.xsd EX-101.SCH 2462
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgmo-20210122_cal.xml EX-101.CAL 747
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgmo-20210122_def.xml EX-101.DEF 1693
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgmo-20210122_lab.xml EX-101.LAB 24270
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgmo-20210122_pre.xml EX-101.PRE 12683
8 EXTRACTED XBRL INSTANCE DOCUMENT sgmo-20210122_htm.xml XML 11575
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 21561597
SIC: 2836 Biological Products, (No Diagnostic Substances)